NUVB
Nuvation Bio·NYSE
--
--(--)
--
--(--)
5.58 / 10
Netural
Analyst consensus is moderate (Strong Buy 33.3%, Buy 33.3%, Neutral 33.3%) with a 3.40 historical weighted rating. Fund-flow data show a 7.76/10 score with overall negative trends in block and medium/large inflows, hinting at selective capital rotation. Together, the analyst and funding view leans cautiously positive but not overwhelming.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
33%
Buy
33%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-21
InstitutionRBC Capital
Times predicted4
Historical Win Rate75.0%
Is money flowing into or out of NUVB?
- NUVB holds a Bearish analyst rating, with 33% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.58/10 (Netural).
